Context dependent reversion of tumor phenotype by connexin-43 expression in MDA-MB231 cells and MCF-7 cells: Role of β-catenin/connexin43 association

Experimental Cell Research

Volumn 319, Issue 20, 2013, Pages 3065-3080

  Talhouk, Rabih S ^a   Fares, Mohamed Bilal ^a,b   Rahme, Gilbert J ^a,c   Hariri, Hanaa H ^a,d   Rayess, Tina ^a,e   Dbouk, Hashem A ^a,f   Bazzoun, Dana ^a   Al Labban, Dania ^a,g   El Sabban, Marwan E ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b EPFL   (Switzerland)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d FLORIDA STATE UNIVERSITY   (United States)

^e Weill Cornell Medical Center   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Breast Cancer; Catenin; Connexin; Gap junction intercellular communication

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ALPHA CATENIN; BETA CATENIN; CONNEXIN 43;

ACINAR CELL; ARTICLE; BREAST ADENOCARCINOMA; BREAST CELL; CANCER CELL; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; EXTRAVASATION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84887209239     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.10.002     Document Type: Article

References (56)

1. Liu Y., Nusrat A., Schnell F.J., Reaves T.A., Walsh S., et al. Human junction adhesion molecule regulates tight junction resealing in epithelia. Journal of Cell Science 2000, 113:2363-2374.
2. Goodenough D.A., Goliger J.A., Paul D.L. Connexins, connexons, and intercellular communication. Annual Review of Biochemistry 1996, 65:475-502.
3. Mesnil M., Crespin S., Avanzo J.L., Zaidan-Dagli M.L. Defective gap junctional intercellular communication in the carcinogenic process. Biochimica et Biophysica Acta 2005, 1719:125-145.
4. Lee S.W., Tomasetto C., Paul D., Keyomarsi K., Sager R. Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. Journal of Cell Biology 1992, 118:1213-1221.
5. Qin H., Shao Q., Curtis H., Galipeau J., Belliveau D.J., et al. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. Journal of Biological Chemistry 2002, 277:29132-29138.
6. Moorby C., Patel M. Dual functions for connexins: Cx43 regulates growth independently of gap junction formation. Experimental Cell Research, 2001, 271:238-248.
7. Zhang Y.W., Kaneda M., Morita I. The gap junction-independent tumorsuppressing effect of connexin 43. Journal of Biological Chemistry 2003, 278:44852-44856.
8. Kalra J., Shao Q., Qin H., Thomas T., Alaoui-Jamali M.A., et al. Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism. Carcinogenesis 2006, 27:2528-2537.
9. Momiyama M., Omori Y., Ishizaki Y., Nishikawa Y., Tokairin T., et al. Connexin26-mediated gap junctional communication reverses the malignant phenotype of MCF-7 breast cancer cells. Cancer Science 2003, 94:501-507.
10. Shao Q., Wang H., McLachlan E., Veitch G.I., Laird D.W. Downregulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Cancer Research 2005, 65:2705-2711.
11. Jiang J.X., Gu S. Gap junction- and hemichannel-independent actions of connexins. Biochimica et Biophysica Acta 2005, 1711:208-214.
12. Kamijo M., Haraguchi T., Tonogi M., Yamane G.Y. The function of connexin 43 on the differentiation of rat bone marrow cells in culture. Biomedical Research 2006, 27:289-295.
13. Sridharan S., Simon L., Meling D.D., Cyr D.G., Gutstein D.E., et al. Proliferation of adult sertoli cells following conditional knockout of the gap junctional protein GJA1 (connexin 43) in mice. Biology of Reproduction 2007, 76:804-812.
14. Yanagiya T., Tanabe A., Hotta K. Gap-junctional communication is required for mitotic clonal expansion during adipogenesis. Obesity 2007, 15:572-582.
15. El-Sabban M.E., Abi-Mosleh L.F., Talhouk R.S. Developmental regulation of gap junctions and their role in mammary epithelial cell differentiation. Journal of Mammary Gland Biology and Neoplasia 2003, 8:463-473.
16. Talhouk R.S., Elble R.C., Bassam R., Daher M., Sfeir A., et al. Developmental expression patterns and regulation of connexins in the mouse mammary gland: expression of connexin30 in lactogenesis. Cell and Tissue Research 2005, 319:49-59.
17. El-Sabban M.E., Sfeir A.J., Daher M.H., Kalaany N.Y., Bassam R.A., et al. ECM-induced gap junctional communication enhances mammary epithelial cell differentiation. Journal of Cell Science 2003, 116:3531-3541.
18. Talhouk R.S., Khalil A.A., Bajjani R., Rahme G.J., El-Sabban M.E. Gap junctions mediate STAT5-independent β-casein expression in CID-9 mammary epithelial cells. Cell Cummunication and Adhesion 2011, 18:104-116.
19. Talhouk R.S., Mroue R., Mokalled M., Abi-Mosleh L., Nehme R., et al. Heterocellular interaction enhances recruitment of β and α-catenins and ZO-2 into functional gap-junction complexes and induces gap junction-dependant differentiation of mammary epithelial cells. Experimental Cell Research 2008, 314:3275-3291.
20. Yao H., Ashihara E., Maekawa T. Targeting the Wnt/β-catenin signaling pathway in human cancers. Expert Opinion on Therapeutic Targets 2011, 7:873-887.
21. Sjölund J., Manetopoulos C., Stockhausen M.T., Axelson H. The Notch pathway in cancer: differentiation gone awry. European Journal of Cancer 2005, 41:2620-2629.
22. El-Saghir J., El-Habre E., El-Sabban M., Talhouk R. Connexins: a junctional crossroad to breast cancer. The International Journal of Developmental Biology 2011, 55:773-780.
23. McLachlan E., Shao Q., Wang H.L., Langlois S., Laird D.W. Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Research 2006, 66:9886-9894.
24. Lee H.S., Seo E.Y., Kang N.E., Kim W.K. Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. The Journal of Nutritional Biochemistry 2008, 19:313-319.
25. Giancotti F.G., Ruoslahti E. Integrin signaling. Science 1999, 285:1028-1032.
26. Stahl S., Weitzman S., Jones J.C. The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis. Journal of Cell Science 1997, 110:55-63.
27. Vinken M., Vanhaecke T., Papeleu P., Snykers S., Henkens T., et al. Connexins and their channels in cell growth and cell death. Cell Signal 2006, 18:592-600.
28. Dbouk H.A., Mroue R.M., El-Sabban M.E., Talhouk R.S. Connexins: a myriad of functions extending beyond assembly of gap junction channels. Cell Communication and Signaling 2009, 7:4.
29. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
30. Czyz J. The stage-specific function of gap junctions during tumourigenesis. Cell Mol. Biol. Lett 2008, 13:92-102.
31. Naus C.C., Bechberger J.F., Caveney S., Wilson J.X. Expression of gap junction genes in astrocytes and C6 glioma cells. Neuroscience Letters 1991, 126:33-36.
32. Soroceanu L., Manning T.J., Sontheimer H. Reduced expression of connexin-43 and functional gap junction coupling in human gliomas. Glia 2001, 33:107-117.
33. Wilgenbus K.K., Kirkpatrick C.J., Knuechel R., Willecke K., Traub O. Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. International Journal of Cancer 1992, 51:522-529.
34. Laird D.W., Fistouris P., Batist G., Alpert L., Huynh H.T. Carystinos GD, Alaoui-Jamali MA: Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Research 1999, 59:4104-4110.
35. Jamieson S., Going J.J., D'arcy R., George D. Expression of gap junction proteins connexin26 and connexin43 in normal human breast and in breast tumors. Journal of Pathology 1998, 184:37-43.
36. El-Sabban M.E., Pauli B.U. Adhesion-mediated gap junctional communication between lung-metastatatic cancer cells and endothelium. Invasion Metastasis 1994, 14:164-176.
37. King T.J., Lampe P.D. The gap junction protein connexin32 is a mouse lung tumor suppressor. Cancer Research 2004, 64:7191-7196.
38. Omori Y., Li Q., Nishikawa Y., Yoshioka T., Yoshida M., et al. Pathological significance of intracytoplasmic connexin proteins: implication in tumor progression. Journal of Membrane Biology 2007, 218:73-77.
39. Ogawa K., Pitchakarn P., Suzuki S., Chewonarin T., Tang M., et al. Silencing of connexin 43 suppresses invasion, migration and lung metastasis of rat hepatocellular carcinoma cells. Cancer Science 2012, 103:860-867.
40. Kanczuga-Koda L., Sulkowski S., Koda M., Skrzydlewska E., Sulkowska M. Connexin 26 correlates with Bcl-xL and Bax proteins expression in colorectal cancer. World Journal of Gastroenterology 2005, 11:1544-1548.
41. Kanczuga-Koda L., Sulkowski S., Tomaszewski J., Koda M., Sulkowska M., et al. Connexins 26 and 43 correlate with Bak, but not with Bcl-2 protein in breast cancer. Oncology Reports 2005, 14:325-329.
42. Cusato K., Bosco A., Rozental R., Guimaraes C.A., Reese B.E., et al. Gap junctions mediate bystander cell death in developing retina. Journal of Neuroscience 2003, 23:6413-6422.
43. Decrock E., Vinken M., De Vuyst E., Krysko D.V., D'Herde K., Vanhaecke, et al. Connexin-related signaling in cell death: to live or let die?. Cell Death & Differentiation 2009, 16:524-536.
44. Gangozo E., Ezan P., Valle-Casuso J., Herrero-Gonzalez S., Koulakoff A., et al. Reduced connexin43 expression correlates with c-Src activation, proliferation, and glucose uptake in reactive astrocytes after an excitotoxic insult. Glia 2012, 60:2040-2049.
45. Zhan L., Rosenberg A., Bergami K., Yu M., Xuan Z., et al. Deregulation of Scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 2008, 135:856-878.
46. Burt J.M., Nelson T.K., Simon A.M., Fang J.S. Connexin 37 profoundly slows cell cycle progression in rat insulinoma cells. Cell Physiology-American Journal of Physiology 2008, 295:1103-1112.
47. Kamei J., Toyofuku T., Hori M. Negative regulation of p21 by betacatenin/TCF signaling: a novel mechanism by which cell adhesion molecules regulate cell proliferation. Biochemical and Biophysical Research Communications 2003, 312:380-387.
48. Sonoda E. Synchronization of cells. Sub-Cellular Biochemistry 2006, 40:415-418.
49. Kota J., Chivukula R.R., O'Donnell K.A., Wentzel E.A., Montgomery C.L., et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137:1005-1017.
50. Graeber S.H., Hulser D.F. Connexin transfection induces invasive properties in HeLa cells. Experimental Cell Research 1998, 243:142-149.
51. Li Z., Zhou Z., Welch D.R., Donahue H.J. Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clinical and Experimental Metastasis 2008, 25:893-901.
52. Zhao W., Han H.B., Zhang Z.Q. Suppression of lung cancer cell invasion and metastasis by connexin43 involves the secretion of follistatin-like 1 mediated via histone acetylation. The International Journal of Biochemistry & Cell Biology 2011, 43:1459-1468.
53. Hatsell S., Rowlands T., Hiremath M., Cowin P. Beta-catenin and tcfs in mammary development and cancer. Journal of Mammary Gland Biology and Neoplasia 2003, 8:145-158.
54. Cowin P., Rowlands T.M., Hatsell S.J. Cadherins and catenins in breast cancer. Current Opinion in Cell Biology 2005, 17:499-508.
55. Weng S., Lauven M., Schaefer T., Polontochouk L., Grover R., et al. Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation. The FASEB Journal 2002, 16:1114-1116.
56. Liu Y., Silverstein F.S., Skoff R., Barks J.D. Hypoxic-ischemic oligodendroglial injury in neonatal rat brain. Pediatriac Research 2002, 51:25-33.